Arphra
Terminal
Monitor
Equities
Fixed Income
Macro & Cross-Asset
Portfolio
Research & AI
Search issuers, ETFs, macro…
⌘K
--:--:--
ET
SR
live
S&P 500
0.34
+0.39%
NASDAQ
0.00
0.00%
DOW
50,872.11
+2.56%
VIX
20.95
+16.00%
US10Y
4.53
+1.21%
EUR/USD
1.1591
-0.11%
GOLD
4,335.2
+0.73%
WTI
81.42
+0.38%
BTC
66,157.93
+0.98%
S&P 500
0.34
+0.39%
NASDAQ
0.00
0.00%
DOW
50,872.11
+2.56%
VIX
20.95
+16.00%
US10Y
4.53
+1.21%
EUR/USD
1.1591
-0.11%
GOLD
4,335.2
+0.73%
WTI
81.42
+0.38%
BTC
66,157.93
+0.98%
S&P 500
0.34
+0.39%
NASDAQ
0.00
0.00%
DOW
50,872.11
+2.56%
VIX
20.95
+16.00%
US10Y
4.53
+1.21%
EUR/USD
1.1591
-0.11%
GOLD
4,335.2
+0.73%
WTI
81.42
+0.38%
BTC
66,157.93
+0.98%
S&P 500
0.34
+0.39%
NASDAQ
0.00
0.00%
DOW
50,872.11
+2.56%
VIX
20.95
+16.00%
US10Y
4.53
+1.21%
EUR/USD
1.1591
-0.11%
GOLD
4,335.2
+0.73%
WTI
81.42
+0.38%
BTC
66,157.93
+0.98%
Monitor
Screen
Issuer
Bonds
FX
Folio
AI
Inbox
CUE
Cue Biopharma, Inc.
Healthcare
Biotechnology
US
USD
Peers →
$25.80
Live
Jun 15, 2026
Watchlist
AI Brief
→
Market cap
$67.8M
52w range
4.98 – 41.42
P / E
—
EPS
—
Volume
78.55K
Revenue · FY
—
Overview
Fundamentals
Market
Ownership & flow
Narrative & AI
Explain this page
Arphra AI
Plain-English read on Cue Biopharma, Inc.’s valuation
…
No corporate actions
No dividend or split records loaded for CUE-US.
Home
Markets
Search
Watch
AI